Literature DB >> 15654526

Haemangiopericytoma of the sigmoid mesentery.

N J West1, I R Daniels, W H Allum.   

Abstract

Haemangiopericytoma is a rare, vascular soft tissue tumour originating from the pericytes surrounding capillaries. We report a case of haemangiopericytoma in the sigmoid mesocolon and are aware of only one previously case. A 61-year-old man was referred with a left iliac fossa mass. At operation, a 10-cm diameter mass was found to be arising from the sigmoid mesentery (Fig. 1). The mass did not involve the bowel wall and there was no clinical evidence of metastatic disease. A sigmoid colectomy with primary anastomosis was performed. The patient made an uneventful recovery. Pathological assessment of the specimen revealed a 95 x 70 x 50 mm(3), purple, lobulated mass within the sigmoid mesocolon adjacent to the bowel. Immunohistological analysis (positive CD34, focal factor VIII) was consistent with a diagnosis of a haemangiopericytoma. Complete excision with adequate margins remains the treatment of choice. We therefore suggest that patients be carefully followed for long periods and advised of the risk of long-term relapse.

Entities:  

Mesh:

Year:  2004        PMID: 15654526     DOI: 10.1007/s10151-004-0084-2

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN: 1123-6337            Impact factor:   3.781


  3 in total

1.  Solitary fibrous tumor arising in the mesentery: a case report.

Authors:  Sarah Bouhabel; Guy Leblanc; Jose Ferreira; Yves E Leclerc; Pierre Dubé; Lucas Sidéris
Journal:  World J Surg Oncol       Date:  2011-10-31       Impact factor: 2.754

2.  Large hemangiopericytoma of the pelvis--towards a multidisciplinary approach.

Authors:  Mohammad Fard-Aghaie; Gregor A Stavrou; Human Honarpisheh; Klaus J Niehaus; Karl J Oldhafer
Journal:  World J Surg Oncol       Date:  2015-08-28       Impact factor: 2.754

Review 3.  Solitary fibrous tumor of the mesentery: a case report and review of the literature.

Authors:  Jing-Ni Liu; Zhao Liu; Peng-Yu Ji; Hong Zhang; Shun-Lin Guo
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.